scholarly article | Q13442814 |
P50 | author | Ingrid Laurendeau | Q114718300 |
Dominique Helley | Q114723636 | ||
Ivan Bièche | Q37240788 | ||
David M. Smadja | Q41895761 | ||
Laurent Muller | Q57006508 | ||
Pascale Gaussem | Q57947811 | ||
Martine Aiach | Q75842644 | ||
P2093 | author name string | Ghislaine Simonin | |
P2860 | cites work | Homeostatic modulation of cell surface KDR and Flt1 expression and expression of the vascular endothelial cell growth factor (VEGF) receptor mRNAs by VEGF | Q22253478 |
Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand | Q24644662 | ||
The biology of VEGF and its receptors | Q27860704 | ||
Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders | Q28646428 | ||
Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria | Q29616614 | ||
Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells | Q30844927 | ||
Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease | Q80833371 | ||
Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases | Q81168941 | ||
High urokinase expression contributes to the angiogenic properties of endothelial cells derived from circulating progenitors | Q83120357 | ||
Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease | Q33200016 | ||
Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. | Q34286784 | ||
Functional disruption of alpha4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization | Q36227849 | ||
The role of circulating precursors in vascular repair and lesion formation. | Q36275663 | ||
Progenitor cells in vascular disease. | Q36275672 | ||
Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). | Q36346473 | ||
Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells | Q36402579 | ||
Clinical and therapeutical implications of EPC biology in atherosclerosis | Q36517055 | ||
Endothelial progenitor cells: characterization, in vitro expansion, and prospects for autologous cell therapy. | Q36763667 | ||
Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells | Q40548115 | ||
Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications | Q40803186 | ||
Involvement of endothelial PECAM-1/CD31 in angiogenesis. | Q42087882 | ||
VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells | Q42677798 | ||
Mobilization of endothelial progenitor cells in patients with acute myocardial infarction | Q43636896 | ||
Expression of vascular endothelial growth factor receptor-2 or Tie-2 on peripheral blood cells defines functionally competent cell populations capable of reendothelialization. | Q45069599 | ||
CD31 (PECAM-1)-bright cells derived from AC133-positive cells in human peripheral blood as endothelial-precursor cells | Q45858746 | ||
Low-molecular-weight fucoidan enhances the proangiogenic phenotype of endothelial progenitor cells. | Q46695289 | ||
Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy. | Q46733681 | ||
Low molecular weight fucoidan and heparin enhance the basic fibroblast growth factor-induced tube formation of endothelial cells through heparan sulfate-dependent alpha6 overexpression. | Q47445041 | ||
The angiopoietin pathway is modulated by PAR-1 activation on human endothelial progenitor cells. | Q50933010 | ||
In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. | Q51059546 | ||
VEGF189 stimulates endothelial cells proliferation and migration in vitro and up-regulates the expression of Flk-1/KDR mRNA. | Q53667872 | ||
An intronic polymorphism in the PAR-1 gene is associated with platelet receptor density and the response to SFLLRN. | Q53857090 | ||
Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase. | Q53888121 | ||
PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system. | Q54645645 | ||
Liver Gene Expression Signature of Mild Fibrosis in Patients With Chronic Hepatitis C | Q57782576 | ||
VEGF and VEGFR-2 (KDR) internalization is required for endothelial recovery during wound healing | Q61697432 | ||
Regulation of endothelial cell morphogenesis by integrins, mechanical forces, and matrix guidance pathways | Q72390027 | ||
Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects | Q73919576 | ||
Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization | Q77323614 | ||
Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration | Q77626680 | ||
Platelets, thrombospondin-1 and human dermal fibroblasts cooperate for stimulation of endothelial cell tubulogenesis through VEGF and PAI-1 regulation | Q79382508 | ||
Outgrowing endothelial progenitor-derived cells display high sensitivity to angiogenesis modulators and delayed senescence | Q80366738 | ||
P433 | issue | 5 | |
P921 | main subject | endothelium | Q111140 |
P304 | page(s) | 1149-1161 | |
P577 | publication date | 2007-09-01 | |
P1433 | published in | Journal of Cellular and Molecular Medicine | Q1524063 |
P1476 | title | Increased VEGFR2 expression during human late endothelial progenitor cells expansion enhances in vitro angiogenesis with up-regulation of integrin alpha(6) | |
P478 | volume | 11 |
Q34441960 | Angiogenesis impairment in diabetes: role of methylglyoxal-induced receptor for advanced glycation endproducts, autophagy and vascular endothelial growth factor receptor 2 |
Q39203508 | Building branched tissue structures: from single cell guidance to coordinated construction. |
Q90462825 | Collagen regulates the ability of endothelial progenitor cells to protect hypoxic myocardium through a mechanism involving miR-377/VE-PTP axis |
Q53509759 | Differentiation of C57/BL6 mice bone marrow mononuclear cells into early endothelial progenitors cells in different culture conditions. |
Q34774629 | Effects of exogenous sonic hedgehog peptide on proliferation, adhesion, migration of endothelial progenitor cells from peripheral blood |
Q90182699 | Efficient differentiation and purification of human induced pluripotent stem cell-derived endothelial progenitor cells and expansion with the use of inhibitors of ROCK, TGF-β, and GSK3β |
Q47694726 | Egfl7 Represses the Vasculogenic Potential of Human Endothelial Progenitor Cells |
Q28072654 | Endothelial Progenitor Cells Physiology and Metabolic Plasticity in Brain Angiogenesis and Blood-Brain Barrier Modeling |
Q37992761 | Endothelial progenitor cells and integrins: adhesive needs |
Q34301563 | Expression of protease-activated receptor 1 and 2 and anti-tubulogenic activity of protease-activated receptor 1 in human endothelial colony-forming cells |
Q90631709 | Fibronectin Adsorption on Electrospun Synthetic Vascular Grafts Attracts Endothelial Progenitor Cells and Promotes Endothelialization in Dynamic In Vitro Culture |
Q92133165 | Gene Editing of α6 Integrin Inhibits Muscle Invasive Networks and Increases Cell-Cell Biophysical Properties in Prostate Cancer |
Q37107833 | Heat-shock protein 60 of Porphyromonas gingivalis may induce dysfunction of human umbilical endothelial cells via regulation of endothelial-nitric oxide synthase and vascular endothelial-cadherin |
Q38656088 | High glucose-induced endothelial progenitor cell dysfunction |
Q35889139 | High-density lipoprotein exerts vasculoprotection via endothelial progenitor cells |
Q37475012 | Hyperoxia disrupts vascular endothelial growth factor-nitric oxide signaling and decreases growth of endothelial colony-forming cells from preterm infants |
Q33861718 | Hypoxia-induced endothelial progenitor cell function is blunted in angiotensinogen knockout mice |
Q37494247 | Impaired function of circulating CD34(+) CD45(-) cells in patients with proliferative diabetic retinopathy |
Q37242381 | In vivo properties of the proangiogenic peptide QK |
Q35187503 | Induction of tumor inhibitory anti-angiogenic response through immunization with interferon Gamma primed placental endothelial cells: ValloVax™. |
Q38202978 | Influence of growth factors and cytokines on angiogenic function of endothelial progenitor cells: a review of in vitro human studies |
Q42439415 | Interleukin 8 is differently expressed and modulated by PAR-1 activation in early and late endothelial progenitor cells. |
Q49630515 | Long term culture and differentiation of endothelial progenitor like cells from rat adipose derived stem cells |
Q35664202 | Long-Term Expansion in Platelet Lysate Increases Growth of Peripheral Blood-Derived Endothelial-Colony Forming Cells and Their Growth Factor-Induced Sprouting Capacity |
Q54357333 | Regulation of endothelial progenitor cell differentiation and function by dimethylarginine dimethylaminohydrolase 2 in an asymmetric dimethylarginine-independent manner. |
Q35212423 | Spinal vascular endothelial growth factor induces phrenic motor facilitation via extracellular signal-regulated kinase and Akt signaling. |
Q92234857 | Standardization of methods to quantify and culture endothelial colony-forming cells derived from peripheral blood: Position paper from the International Society on Thrombosis and Haemostasis SSC |
Q58595974 | Stem/Progenitor Cells and Their Therapeutic Application in Cardiovascular Disease |
Q39221799 | T17b murine embryonal endothelial progenitor cells can be induced towards both proliferation and differentiation in a fibrin matrix. |
Q52646840 | Targeting VEGFR1 on endothelial progenitors modulates their differentiation potential. |
Q42565183 | The Role of Endothelial Progenitor Cells in Postnatal Vasculogenesis: Implications for Therapeutic Neovascularization and Wound Healing |
Q52726257 | The development of an extra-anatomic tissue-engineered artery with collateral arteries for therapeutic angiogenesis in ischemic hind limb. |
Q35458444 | Thrombin bound to a fibrin clot confers angiogenic and haemostatic properties on endothelial progenitor cells |
Q53221287 | Thrombin receptor PAR-1 activation on endothelial progenitor cells enhances chemotaxis-associated genes expression and leukocyte recruitment by a COX-2-dependent mechanism. |
Q57767280 | Thérapie génique et cellulaire dans le traitement des pathologies ischémiques des membres inférieurs |
Q41895695 | Treprostinil increases the number and angiogenic potential of endothelial progenitor cells in children with pulmonary hypertension |
Q57767223 | Treprostinil indirectly regulates endothelial colony forming cell angiogenic properties by increasing VEGF-A produced by mesenchymal stem cells |
Q37620426 | α6-Integrin is required for the adhesion and vasculogenic potential of hemangioma stem cells |
Search more.